. Introduction {#s02}
==============

Polycystic kidney disease (PKD) is a disease where enlarged kidneys develop characteristic fluid-filled cysts. Cysts in the liver or pancreas, cerebral aneurysms, abnormal cardiac development, and hypertension are also frequently found in PKD patients. Genetic studies have shown that approximately 80% of autosomal dominant PKD (ADPKD) is caused by mutations in the PKD1 gene (encoding polycystin-1, PC1), and about 20% of ADPKD was due to mutations in PKD2 gene (encoding polycystin-2, PC2). It has been extensively shown that PC1/2 act as the key regulators for calcium homeostasis, and the dysfunction of PC1/2 might play an essential role in calcium imbalance and cAMP signaling, resulting in the development of PKD phenotypes^[@b1],[@b2]^. Increasing evidence suggests that PC1/2 proteins might interact with key regulators in cell cycle regulation, especially in cell proliferation and secretion-related signaling pathways^[@b1]^. PKD1 has been found to play a role in preventing immortalized proliferation of renal cells through p53 and JNK, suggesting a novel link between PKD1 and p53^[@b3]^. It has also been found that the tumor suppressor protein p53 participates in a negative feedback loop to regulate PKD1 gene expression, thus preventing renal cysts formation^[@b4]^. Interestingly, another study has shown that Mekk1 acts as a co-repressor with p53 to downregulate PKD1 transcription. This PKD1 repression could be promoted by stress stimuli, suggesting that abnormally elevated stress responses might directly downregulate the PKD1 gene, possibly causing haploinsufficiency and cyst formation^[@b5]^. In an endothelial cell-culture system, elevated expression of mechanosensory polycystins in human carotid atherosclerotic plaques is associated with p53 activation and disease severity^[@b6]^. At the animal level, Bcl2 knockout mice manifested PKD and PKD phenotypes that could not have been rescued by p53 deficiency^[@b7],[@b8]^. The mutant p53 protein, especially the missense point mutation, is the major form of p53 deficiency in human disease. It promotes the progress of disease by both loss and gain of function^[@b9]^. However, no evidence has been found to connect mutant p53 with the progress of PKD.

Werner syndrome (WS) protein is a member of the RecQ helicase family implicated in the maintenance of genome stability. WRN plays an essential role in telomere DNA replication, and WRN defects cause human pathologies linked to cancer predisposition and premature aging, such as WS^[@b10]-[@b12]^. By masking the chromosome ends from the DNA repair machinery through repression of the ATM/ATR signaling pathways, telomere DNA has a crucial function in DNA damage response (DDR). Telomere DNA is elongated by telomerase and protected by the protein complex shelterin, which regulates telomere length and protects telomeres from activating DDR^[@b13]^.

The mouse model of WS is established by double knockout of WRN and the RNA component of telomerase. The late generation (G4-6) of WS mice with both telomerase and WRN deficiency (*mTR*^-/-^*WRN*^-/-^) exhibited the clinical features observed in WS patients^[@b14]-[@b16]^. Our previous study has shown that ALT tumorigenic cell lines derived from senescent WS MEFs gained the same point mutation in tumor suppressor gene Trp53, encoding a mutant p53 protein known as p53N236S (p53S hereafter). The p53^S/S^ mice manifested highly invasive lymphomas and metastatic sarcomas with dramatically increased double minute chromosomes^[@b17]^.

We introduced this p53S mutation back into WS mice to study the intrinsic role of p53S in modulating WS symptoms, by crossing mice carrying p53S mutation with WS mice. Surprisingly, we found that the offspring of p53S and WS mice (*mTR*^-/-^*WRN*^-/-^*p53*^*S*/*S*^) manifested both PKD and tumor phenotypes. Here we report the phenotypes of this novel mouse model. By RNA-seq and ssGSEA analysis, we have identified the gene signatures and pathways that connect mutant p53 and telomere dysfunction with the development of PKD.

. Materials and methods {#s03}
=======================

. Mice {#s03.01}
------

Transgenic p53S mice and WS (*mTR*^-/-^*WRN*^-/-^) mice were bred to generate *mTR*^-/-^*WRN*^-/-^*p53*^*S*/*S*^ mice. We crossed mice carrying p53S mutation (*p53*^*S*/*S*^) with WS mice (*mTR*^-/-^*WRN*^-/-^) and obtained the first generation of mice with telomerase knockout, *WRN* knockout, and p53S mutation (G1 *mTR*^-/-^*WRN*^-/-^*p53*^*S*/*S*^), referred to as G1 triple mutation (G1TM). The mice were then bred generation-by-generation to obtain G2 and G3 TM mice. The telomerase knockout and *WRN* knockout mice (double mutation, DM) and wild type (WT) mice were used as control. All experiments were carried out with the approval of the Kunming University of Science and Technology and Use Committee (Approval ID: M2015-011) in accordance with the guidelines of the Association for Assessment and Accreditation of Laboratory Animal Care.

. MEF cells {#s03.02}
-----------

The MEF cells with different genotypes were harvested in 13.5 days and cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) at 37 °C with 5% CO~2~ and 3% O~2~. To maintain their original characteristics, only the early passages (≤ passage 5) of MEF cells were used for experiments.

. Pathology analysis {#s03.03}
--------------------

Mouse kidney samples were fixed in 4% neutral buffered formalin for 6 hours, then alcohol-dehydrated and paraffin-embedded. The paraffin-embedded tissue blocks were sectioned into 4 μm slices for later experiments. For hematoxylin-eosin (HE) staining, the tissue sections were deparaffinized and rehydrated, and H&E staining was applied. The H&E stained slides were observed via microscopy and the histological changes and kidney lesions were evaluated by pathologists.

. RNA-seq and gene expression signature analysis {#s03.04}
------------------------------------------------

Cell or tissue (sarcoma and cystic kidney) samples were collected and sent for commercia RNA-seq service (Novogene, China). Briefly, the total RNA was extracted and enriched by oligo-dT labeled magnetic beads, and used to construct a library for RNA-seq. The sequenced reads (raw reads) were evaluated for quality control. The adapters and low quality reads were filtered to obtain clean reads. The clean data were then aligned with the reference mouse genome by TopHat2. The RNA-seq counts were annotated and the FPKM file was generated for bioinformatic analysis.

The Bioinformatics ExperT SYstem (BETSY) was applied to automate the development of workflows^[@b18]^. The single sample gene set enrichment analysis (ssGSEA)^[@b19]^was applied to analyze the RNA-seq data. Hallmark (designed for well-defined biological states and processes), C2 (BIOCARTA, KEGG, REACTOME, etc.), and C5 (GO) gene sets from the Molecular Signatures Database^[@b20]^were used for ssGSEA analysis. The heat maps were plotted with BETSY by centering with mean but without hierarchical clustering. The common pathways between cystic kidneys and tumors were ranked and plotted based on their ssGSEA scores.

. Ingenuity pathway analysis {#s03.05}
----------------------------

The essential genes involved in PKD development were selected according to the literature^[@b1],[@b21]^. The fold change in their expression between G3TM and G3DM was calculated from RNA-seq data. After applying the cutoff (2 ×) for gene expression fold change, the remaining genes and their fold changes, and *P* values were imported to Ingenuity Pathway Analysis (IPA) software. The knowledge base of IPA were used to draw their expression regulation and interaction network. The network with largest numbers of genes is included, such as developmental disorders, immunological diseases, inflammatory diseases, inflammatory response, and renal and urological disease.

. Quantitative real-time PCR analysis {#s03.06}
-------------------------------------

RNA was isolated from cell or tissue samples, and cDNA was synthesized by reverse transcription. Real-time PCR was performed on an ABI Prism 7300 sequence detection system with SYBR-Green PCR master mix according to the manufacturer's instructions (Applied Biosystems, CA). The primers used are as follows:

PKD1, forward primer: 5'-CCCTCTCGGAGCAGAATCAAT-3', reverse primer: 5'-GTGTTGAGCTAATGGGCAGG-3';

PKD2, forward primer: 5'-GGGGAACAAGACTCATGGAAG-3', reverse primer: 5'-GCCGTAGGTCAAGATGCACAA-3';

Pkhd1, forward primer:5'-GGGAGGTCGATGGTGCATAAG-3', reverse primer: 5'-GATGTCCGTTCTTCCCCCAAG-3';

Hnf1b, forward primer: 5'-AGGGAGGTGGTCGATGTCA-3', reverse primer: 5'-TCTGGACTGTCTGGTTGAACT-3';

C2, forward primer: 5'-CGGTGGTAATTTCACCCTCAG-3', reverse primer: 5'-GGTGTGATGTGAGCTAGACCT-3';

C5, forward primer: 5'-GAACAAACCTACGTCATTTCAGC-3', reverse primer 5'-GTCAACAGTGCCGCGTTTT-3';

Pgc1a, forward primer: 5'-TATGGAGTGACATAGAGTGTGCT-3', reverse primer: 5'-CCACTTCAATCCACCCAGAAAG-3';

Tfam, forward primer: 5'-ATTCCGAAGTGTTTTTCCAGCA-3', reverse primer: 5'-TCTGAAAGTTTTGCATCTGGGT-3';

Wnt1, forward primer: 5'-GGTTTCTACTACGTTGCTACTGG-3', reverse primer: 5'-GGAATCCGTCAACAGGTTCGT-3';

Ctnnb1, forward primer: 5'-ATGGAGCCGGACAGAAAAGC-3', reverse primer: 5'-CTTGCCACTCAGGGAAGGA-3';

Srebf1, forward primer: 5'-GATGTGCGAACTGGACACAG-3', reverse primer: 5'-CATAGGGGGCGTCAAACAG-3';

Srebf2, forward primer: 5'-GCAGCAACGGGACCATTCT-3', reverse primer: 5'-CCCCATGACTAAGTCCTTCAACT-3';

β-actin, forward primer: 5'-AGAGGGAAATCGTGCGTGAC-3', reverse primer: 5'-CAATAGTGATGACCTGGCCGT-3'.

. Results {#s04}
=========

. Generation of a mouse model manifesting PKD phenotypes {#s04.01}
--------------------------------------------------------

We crossed mice carrying p53S mutation with WS mice and obtained the first generation of mice with telomerase, *WRN* knockout, and p53S mutations (G1*mTR*^-/-^*WRN*^-/-^*p53*^*S*/*S*^), referred to as G1 triple mutation (G1TM). The mice were then bred generation-by-generation to obtain G2 and G3 TM mice (**[Figure 1A](#Figure1){ref-type="fig"}** and **[1B](#Figure1){ref-type="fig"}**).

![Generation of a mouse model manifesting PKD.](cbm-16-1-79-1){#Figure1}

As expected, we observed the incidence of sarcomas when telomere length was shortened to a certain level, which occurred in G3TM (G3*mTR*^-/-^*WRN*^-/-^*p53*^*S*/*S*^) mice (**[Figure 1C](#Figure1){ref-type="fig"}**). The affected mice were sacrificed and anatomical analysis showed that the mice also manifested unilateral or bilateral enlarged kidneys with multiple fluid-filled cysts (**[Figure 1D](#Figure1){ref-type="fig"}**). Thus, surprisingly, PKD phenotypes were found in G3TM mice at around 4 months old.

The H&E of the kidney sections showed that the kidneys from wild type mice developed normal renal tubules and glomeruli (**[Figure 2A](#Figure2){ref-type="fig"}**), while the kidneys from G3TM mice displayed a range of phenotypes associated with renal dysplasia and renal cyst formation. In the G3TM mouse EH85, the normal histological structure of the right kidney was completely replaced by fluid-filled cysts of various sizes (**[Figure 2B](#Figure2){ref-type="fig"}**). At higher magnification, we could observe that the renal tubules and glomeruli were compressed and atrophied, and the glomerulus lost its capillary loop structure completely (**[Figure 2C](#Figure2){ref-type="fig"}**). These data show the severe fluid-filled cyst formation and total loss of renal function in this kidney. In the kidney from G3TM mouse EJ08, cellular swelling or hydropic degeneration and vacuolation were observed (**[Figure 2D](#Figure2){ref-type="fig"}**), suggesting the dysfunction of ion and water regulation in these renal cells. In the kidneys from G3TM mouse EM06, the cyst is surrounded by flat epithelial cells, which suggests that cellular morphological changes are caused by fluid pressure from the cyst (**[Figure 2E](#Figure2){ref-type="fig"}**). In the kidney from G3TM mouse CS87, we found the abnormal glomerulus with poorly defined capillary loop (**[Figure 2F](#Figure2){ref-type="fig"}**). The abnormal glomerulus with semi-enclosed capillary loop was also frequently observed, indicating the loss of glomerulus function and downregulation of blood filtering function.

![Hematoxylin and eosin staining of kidney sections from mice with PKD phenotype.](cbm-16-1-79-2){#Figure2}

Together these data suggest that kidneys from G3*mTR*^-/-^*WRN*^-/-^*p53*^*S*/*S*^ mice were hypoplastic and developed PKD phenotypes.

. The correlation of tumorigenesis and PKD phenotypes {#s04.02}
-----------------------------------------------------

As described earlier, the G3TM mice should manifest phenotypes that correlate with abnormal DNA damage response and abnormal proliferation. In our case, it manifested as increased tumorigenesis and PKD formation. To further understand the relationship between abnormal DNA damage response, tumorigenesis, and PKD phenotypes, we analyzed the frequencies and co-occurrence of cystic kidney and tumorigenesis in mice groups with different genotypes.

We did not find any tumorigenesis or PKD in those mice with WRN and telomerase double knockout, including G1DM mice (*n*=41), G2DM mice (*n*=52), and G3DM (*n*=63). However, we observed a few PKD or tumor incidences in G1TM and G2TM mice; this number increased dramatically in G3TM mice (**[Table 1](#Table1){ref-type="table"}**, **[Figure 3A](#Figure3){ref-type="fig"}**). The incidence increased along with telomere shortening (G1-G2-G3) and the introduction of p53S (TM *vs.* DM). These data strongly suggest that interplay of telomere DNA damage and p53S mutation contributed to the development of PKD. Furthermore, most PKD co-occurred with tumor phenotypes (**[Table 1](#Table1){ref-type="table"}**, **[Figure 3A](#Figure3){ref-type="fig"}**), showing that the occurrence of PKD phenotype was highly correlated with increased tumorigenesis.

###### 

The occurrence of cystic kidney and/or tumor in mice with different genotypes

  Number of mice         G1DM   G1 TM   G2 DM   G2 TM   G3 DM   G3 TM
  ---------------------- ------ ------- ------- ------- ------- -------
  Cystic kidney          0      1       0       2       0       4
  Tumor                  0      5       0       9       0       23
  Cystic kidney+ tumor   0      5       0       9       0       23
  Total                  41     21      52      39      63      43

![Co-occurrence of tumorigenesis with PKD and gene signature analysis.](cbm-16-1-79-3){#Figure3}

. Gene signatures of PKD caused by telomere dysfunction and p53S mutation {#s04.03}
-------------------------------------------------------------------------

Since the genetic defect in this PKD model is very different from classical PKD models with polycystins defects, we were interested in investigating the gene signatures in MEFs (G3TM), cystic kidneys, and tumors from G3TM. We compared the gene expression profiles in MEFs from G1DM to G3TM mice using RNA-seq and ssGSEA analysis, as well as the tumors and cystic kidneys from G3TM mice.

First, we analyzed the gene signatures that were upregulated or downregulated in cystic kidneys using the Hallmark dataset. We found that the metabolism-related pathways, particularly lipid metabolism, were strikingly upregulated in cystic kidneys. These included bile acid metabolism, fatty acid metabolism and others (**[Figure 3B](#Figure3){ref-type="fig"}**). Cell cycle-related pathways were clearly downregulated, such as mitotic spindle, G2M checkpoint, and E2F targets. (**[Figure 3B](#Figure3){ref-type="fig"}**). These data suggest that abnormal metabolic regulation contributed greatly to PKD progress in G3TM mice.

Interestingly, the pathways such as oxidative phosphorylation, complement, and interferon alpha gamma were upregulated in both cystic kidneys and tumors (**[Figure 3B](#Figure3){ref-type="fig"}**). These common regulated pathways suggest that the development of cystic kidney shares common mechanisms with tumorigenesis.

We then expanded the ssGSEA analysis by combining the Hallmark, C2, and C5 datasets^[@b20]^, and mapping the gene signatures that were gradually upregulated or downregulated in G3TM cells, tumors, and cystic kidneys (**[Supplementary Figure S1](#Figure1){ref-type="fig"}** and **[S2](#Figure2){ref-type="fig"}**). The data revealed that most strikingly upregulated pathways shared by tumors and cystic kidneys included complement pathways, the immune response, lipid metabolism, and mitochondrial energy homeostasis. Interestingly, we observed that kidney function-related pathways, such as microvillus organization and water homeostasis, were upregulated in both tumors and kidneys. The data also show that organic cation transport and glucuronidation pathways were highly upregulated in cystic kidneys (**[Supplementary Figure S1](#FigureS1){ref-type="fig"}**).

![A heatmap of gene expression profiles (ssGSEA analysis results of the RNA-seq data using Hallmark, C2, and C5 datasets) in MEFs from G1DM, G2DM, G3DM, G1TM, G2TM, and G3TM mice, as well as the tumors and cystic kidneys from G3TM mice. The pathways were ranked by scores, showing upregulation in cystic kidney, as well as in the tumor and G3TM MEFs.](cbm-16-1-79-S1){#FigureS1}

On the other hand, the pathways obviously downregulated in tumor and kidneys included cytoskeleton regulation, extracellular signal transduction and others (**[Supplementary Figure S2](#Figure2){ref-type="fig"}**). Together, regulation of these pathways revealed that G3TM PKD shares common mechanisms with tumorigenesis. These dysfunctions of gene regulation composed the gene signatures of G3TM PKD.

. Comparison of gene signatures in PKD caused by telomere dysfunction and p53S mutation with classical PKD caused by PKD1 or PKD2 deficiency {#s04.04}
--------------------------------------------------------------------------------------------------------------------------------------------

After analyzing the gene signatures in the G3TM PKD model (G3*mTR*^-/-^*WRN*^-/-^*p53*^*S*/*S*^), we compared the gene signatures in this model with classic PKD models with PKD1 or PKD2 deficiency. We analyzed RNA-seq data of the classic PKD models with PKD1 or PKD2 deficiency^[@b22]^ by the same ssGSEA analysis, and compared gene signatures between the three mouse models. The data, analyzed by the Hallmark dataset, showed that the common upregulated pathways among these three PKD models included complement, coagulation, and apical surface, whereas the common downregulated pathways included angiogenesis (**[Supplementary Table S1](#TableS1){ref-type="table"}**).

###### 

The common pathways shared by G3TM PKD and Pkd1/2-deficient PKD revealed by ssGSEA analysis results of the RNA-seq data using the Hallmark dataset

  ----------------------------------------------------------------------------------------------------------
  Up-regulated in G3TM PKD   Down-regulated in G3TM PKD                              
  -------------------------- ---------------------------- -------------------------- -----------------------
  Up-regulated\              Up-regulated\                Down-regulated\            Down-reulated\
  in Pkd1 deficient PKD      in Pkd2 deficient PKD        in Pkd1 deficient PKD      in Pkd2 deficient PKD

  HALLMARK_APICAL_SURFACE    HALLMARK_ANDROGEN_RESPONSE   HALLMARK_ANGIOGENESIS      HALLMARK_ANGIOGENESIS

  HALLMARK_COAGULATION       HALLMARK_APICAL_SURFACE      HALLMARK_GLYCOLYSIS        HALLMARK\_\
                                                                                     SPERMATOGENESIS

  HALLMARK_COMPLEMENT        HALLMARK\_\                  HALLMARK_MITOTIC_SPINDLE   
                             CHOLESTEROL_HOMEOSTASIS                                 

  HALLMARK\_\                HALLMARK_COAGULATION         HALLMARK_MYOGENESIS        
  ESTROGEN_RESPONSE_LATE                                                             

  HALLMARK\_\                HALLMARK_COMPLEMENT          HALLMARK_PI3K_AKT\_\       
  KRAS_SIGNALING_DN                                       MTOR_SIGNALING             

                             HALLMARK\_\                  HALLMARK_UV_RESPONSE_DN    
                             ESTROGEN_RESPONSE_EARLY                                 

                             HALLMARK\_\                                             
                             ESTROGEN_RESPONSE_LATE                                  

                             HALLMARK\_\                                             
                             INTERFERON_ALPHA_RESPONSE                               

                             HALLMARK\_\                                             
                             INTERFERON_GAMMA_RESPONSE                               

                             HALLMARK\_\                                             
                             PANCREAS_BETA_CELLS                                     

                             HALLMARK\_\                                             
                             PROTEIN_SECRETION                                       
  ----------------------------------------------------------------------------------------------------------

The expanded analysis with Hallmark, C2, and C5 datasets revealed that common upregulated pathways included complement activation, bile acid metabolism, and ion homeostasis. The common downregulated pathways included cell-to-cell adhesion signaling and epithelial structural maintenance (**[Supplementary Table S2](#TableS2){ref-type="table"}**).

###### 

The common pathways shared by G3TM PKD and Pkd1/2-deficient PKD revealed by ssGSEA analysis results of the RNA-seq data using Hallmark, C2, and C5 dataset

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Up-regulated in G3TM PKD                                                                                                                                                                     Down-regulated in G3TM PKD                                                                                                                                                                  
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------
  Up-regulated\                                                                                                                                                                                Up-regulated\                                                                              Down-regulated\                                                                                  Down-regulated\
  in Pkd1 deficient PKD                                                                                                                                                                        in Pkd2 deficient PKD                                                                      in Pkd1 deficient PKD                                                                            in Pkd2 deficient PKD

  AIGNER_ZEB1_TARGETS                                                                                                                                                                          AIGNER_ZEB1_TARGETS                                                                        AMIT_SERUM\_\                                                                                    BECKER_TAMOXIFEN\_\
                                                                                                                                                                                                                                                                                          RESPONSE_240_MCF10A                                                                              RESISTANCE_UP

  BANDRES_RESPONSE_TO\_\                                                                                                                                                                       BIOCARTA_COMP_PATHWAY                                                                      BARIS_THYROID_CANCER_DN                                                                          BIOCARTA\_\
  CARMUSTIN_WITHOUT\_\                                                                                                                                                                                                                                                                                                                                                                     CELL2CELL_PATHWAY
  MGMT_24HR_UP                                                                                                                                                                                                                                                                                                                                                                             

  BIOCARTA_COMP_PATHWAY                                                                                                                                                                        BROWNE_HCMV\_\                                                                             BECKER_TAMOXIFEN\_\                                                                              BIOCARTA_GCR_PATHWAY
                                                                                                                                                                                               INFECTION_48HR_UP                                                                          RESISTANCE_UP                                                                                    

  DACOSTA_UV_RESPONSE\_\                                                                                                                                                                       DACOSTA_UV_RESPONSE\_\                                                                     BIOCARTA\_\                                                                                      BIOCARTA_NO2IL12_PATHWAY
  VIA_ERCC3_COMMON_UP                                                                                                                                                                          VIA_ERCC3_COMMON_UP                                                                        ELL2CELL_PATHWAY                                                                                 

  DURCHDEWALD_SKIN\_\                                                                                                                                                                          DURCHDEWALD_SKIN\_\                                                                        BIOCARTA_IL2RB_PATHWAY                                                                           BIOCARTA\_\
  CARCINOGENESIS_UP                                                                                                                                                                            CARCINOGENESIS_UP                                                                                                                                                                           P53HYPOXIA_PATHWAY

  FIGUEROA_AML_METHYLATION_CLUSTER_4\_UP                                                                                                                                                       ENGELMANN_CANCER\_\                                                                        BIOCARTA_SODD_PATHWAY                                                                            BIOCARTA_TALL1_PATHWAY
                                                                                                                                                                                               PROGENITORS_DN                                                                                                                                                                              

  FURUKAWA_DUSP6\_\                                                                                                                                                                            FIGUEROA_AML\_\                                                                            BOWIE_RESPONSE\_\                                                                                BROWNE_INTERFERON\_\
  TARGETS_PCI35_UP                                                                                                                                                                             METHYLATION_CLUSTER_4\_UP                                                                  TO_EXTRACELLULAR_MATRIX                                                                          RESPONSIVE_GENES

  GO\_\_DE_NOVO\_\                                                                                                                                                                             FURUKAWA_DUSP6\_\                                                                          BROWNE_INTERFERON\_\                                                                             CHAN_INTERFERON\_\
  POSTTRANSLATIONAL\_\                                                                                                                                                                         TARGETS_PCI35_UP                                                                           RESPONSIVE_GENES                                                                                 PRODUCING_DENDRITIC_CELL
  PROTEIN_FOLDING                                                                                                                                                                                                                                                                                                                                                                          

  GO\_\_DE_NOVO\_\                                                                                                                                                                             GO\_\_DE_NOVO_P\                                                                           BURTON_ADIPOGENESIS_12                                                                           CHEMELLO_SOLEUS_VS\_\
  PROTEIN_FOLDING                                                                                                                                                                              OSTTRANSLATIONAL\_\                                                                                                                                                                         EDL_MYOFIBERS_DN
                                                                                                                                                                                               PROTEIN_FOLDING                                                                                                                                                                             

  GO_2\_IRON_2\_SULFUR\_\                                                                                                                                                                      GO\_\_DE_NOVO\_\                                                                           CHAN_INTERFERON\_\                                                                               CHIANG_LIVER_CANCER\_\
  CLUSTER_BINDING                                                                                                                                                                              PROTEIN_FOLDING                                                                            PRODUCING_DENDRITIC_CELL                                                                         SUBCLASS_INTERFERON_UP

  GO_AMMONIUM_ION_BINDING                                                                                                                                                                      GO_ACTIN_NUCLEATION                                                                        CHEMELLO_SOLEUS_VS\_\                                                                            CLIMENT_BREAST_CANCER\_\
                                                                                                                                                                                                                                                                                          EDL_MYOFIBERS_DN                                                                                 COPY_NUMBER_UP

  GO_APOPTOTIC\_\                                                                                                                                                                              GO_APOPTOTIC\_\                                                                            CLIMENT_BREAST_CANCER\_\                                                                         DAUER_STAT3_TARGETS_DN
  MITOCHONDRIAL_CHANGES                                                                                                                                                                        MITOCHONDRIAL_CHANGES                                                                      COPY_NUMBER_UP                                                                                   

  GO_BILE_ACID\_\                                                                                                                                                                              GO_BILE_ACID\_\                                                                            CROONQUIST_STROMAL\_\                                                                            DOANE_BREAST_CANCER\_\
  METABOLIC_PROCESS                                                                                                                                                                            METABOLIC_PROCESS                                                                          STIMULATION_DN                                                                                   CLASSES_DN

  GO_BRAIN_MORPHOGENESIS                                                                                                                                                                       GO_BROWN_FAT\_\                                                                            DAUER_STAT3_TARGETS_DN                                                                           DUTTA_APOPTOSIS_VIA_NFKB
                                                                                                                                                                                               CELL_DIFFERENTIATION                                                                                                                                                                        

  GO_BROWN_FAT\_\                                                                                                                                                                              GO_CELL_MATURATION                                                                         DORN_ADENOVIRUS\_\                                                                               EINAV_INTERFERON\_\
  CELL_DIFFERENTIATION                                                                                                                                                                                                                                                                    INFECTION_32HR_UP                                                                                SIGNATURE_IN_CANCER

  GO_CALCIUM_INDEPENDENT\_\                                                                                                                                                                    GO_CELLULAR_IRON_ION_HOMEOSTASIS                                                           DORN_ADENOVIRUS_INFECTION_48HR_UP                                                                FARMER_BREAST_CANCER_CLUSTER_1
  CELL_CELL_ADHESION_VIA\_\                                                                                                                                                                                                                                                                                                                                                                
  PLASMA_MEMBRANE_CELL\_\                                                                                                                                                                                                                                                                                                                                                                  
  ADHESION_MOLECULES                                                                                                                                                                                                                                                                                                                                                                       

  GO_CATECHOLAMINE_BINDING                                                                                                                                                                     GO_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY                                             DUTTA_APOPTOSIS_VIA_NFKB                                                                         FERRANDO_LYL1_NEIGHBORS

  GO_CELLULAR_IRON_ION_HOMEOSTASIS                                                                                                                                                             GO_COMPLEMENT_ACTIVATION                                                                   EINAV_INTERFERON_SIGNATURE_IN_CANCER                                                             GAUSSMANN_MLL_AF4_FUSION_TARGETS_F\_DN

  GO_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY                                                                                                                                               GO_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY                                               FIGUEROA_AML_METHYLATION_CLUSTER_5\_DN                                                           GO_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY

  GO_CHYLOMICRON                                                                                                                                                                               GO_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT                                                       FINETTI_BREAST_CANCER_KINOME_GREEN                                                               GO_ACTIN_FILAMENT_POLYMERIZATION

  GO_COMPLEMENT_ACTIVATION                                                                                                                                                                     GO_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE                  FUNG_IL2_SIGNALING_2                                                                             GO_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY

  GO_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY                                                                                                                                                 GO_DYNEIN_BINDING                                                                          GAUSSMANN_MLL_AF4_FUSION_TARGETS_F\_DN                                                           GO_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY

  GO_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT                                                                                                                                                         GO_ERBB2_SIGNALING_PATHWAY                                                                 GAVIN_FOXP3_TARGETS_CLUSTER_T7                                                                   GO_ADENYLATE_CYCLASE_ACTIVATING_G\_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY

  GO_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE                                                                                                                    GO_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS                                                   GENTILE_UV_RESPONSE_CLUSTER_D1                                                                   GO_ADENYLATE_CYCLASE_MODULATING_G\_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY

  GO_DETOXIFICATION                                                                                                                                                                            GO_GAS_TRANSPORT                                                                           GO_14_3\_3_PROTEIN_BINDING                                                                       GO_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY

  GO_ENDOCYTIC_VESICLE_LUMEN                                                                                                                                                                   GO_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN                          GO_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY                                                      GO_AXON_REGENERATION

  GO_EPOXYGENASE_P450_PATHWAY                                                                                                                                                                  GO_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES   GO_ACROSOME_ASSEMBLY                                                                             GO_B\_CELL_RECEPTOR_SIGNALING_PATHWAY
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Together these data reveal that although the G3TM PKD model was derived from different genetic aberrations to classical PKD models, they share common pathways in regulating complement activation, lipid metabolism, cell-to-cell adhesion signaling etc. These pathways might play an essential role in PKD development.

Furthermore, we found that from G1DM to G3TM, along with the introduction of p53S mutation and telomere shortening, the expression levels of PKD1 and PKD2 decreased significantly (**[Figure 3C](#Figure3){ref-type="fig"}**), suggesting that p53S mutation could downregulate PKD1 and PKD2 expression. In the end-stage tumor and cystic kidney tissues, the PKD2 level was slightly upregulated, but was still lower than the level in G3DM (**[Figure 3C](#Figure3){ref-type="fig"}**).

Since G3TM is the genotype with most incidences of tumor and cystic kidney disease, but not G3DM, comparison of gene regulation in G3TM with G3DM might provide the mechanisms for PKD attributed to p53S. We evaluated the genes essential for classical PKD development^[@b1],[@b21]^, and mapped their interaction networks with IPA (**[Figure 3D](#Figure3){ref-type="fig"}**). Based on expression fold-changes of genes in this interaction network, the molecule activity predictor showed that cystic kidney module was significantly activated (*P*-value: 3.31E-11). Other than PKD1 and PKD2, the ARPKD protein Pkhd1 (polyductin) and its transcriptional factor Hnf1b (hepatocyte nuclear factor 1 homeobox B)^[@b23]^ were also downregulated. These data suggest that p53S plays a role in transcriptional regulation of PKD-related genes.

To validate the key genes in altered pathways as revealed by RNA-seq data, we further analyzed the regulation of genes involved in the PKD pathway, complement pathway, mitochondria pathway, Wnt signaling pathway, and lipid metabolism pathway by quantitative real-time PCR. Compared with WT and G3DM MEFs, the expression of PKD genes PKD1, PKD2, Pkhd1, and Hnf1b was suppressed in G3TM MEFs. However, complement pathway genes C2 and C5; mitochondria pathway genes Pgc1a and Tfam; Wnt signaling pathway genes Wnt1 and Ctnnb1; and lipid metabolism pathway genes Srebf1 and Srebf2 were upregulated in G3TM MEFs (**[Figure 3E](#Figure3){ref-type="fig"}**). These data further confirmed the RNA-seq data, and suggest that p53S regulates genes involved in the aforementioned pathways attributed to the development of cystic kidney.

. Discussion {#s05}
============

It has always been suspected that the development of cystic kidney disease shares features with tumorigenesis, although the evidence is unclear^[@b24],[@b25]^. Recent understanding of aberrant downstream pathways in ADPKD demonstrates that transcriptional functions that regulate cell cycle progression, energy metabolism, and secretion-related signaling are abnormal in PKD^[@b1]^, and p53 is the essential node in all these transcriptional regulations^[@b26]^.

It has always been documented that wild type p53 could bind to the PKD1 promoter, and the kidneys of p53 null mice expressed higher PKD1 mRNA levels than wild-type littermates, suggesting that wild type p53 suppressed the expression of PKD1^[@b4]^. It has also been shown that depletion of PKD1 led to increased cell proliferation and caused a premature G1/S transition, and the elevated expression of mechanosensory polycystins in human carotid atherosclerotic plaques was associated with p53 activation^[@b6],[@b27]^. Thus, it is conceivable that mutant p53, which loses the wild type function of p53 and gains oncogenic function, plays an important role in the development of PKD.

Here we revealed a novel PKD and tumor combined mouse model (PKD derived from G3*mTR*^-/-^*WRN*^-/-^*p53*^*S*/*S*^ mice) (**[Figure 1](#Figure1){ref-type="fig"}** and **[2](#Figure2){ref-type="fig"}**). The co-occurrence of cystic kidneys and tumors suggests common genetic mechanisms, which in this case could be DNA damage caused by telomere dysfunction and the abnormal DNA damage response, cellular proliferation, or metabolic dysregulation caused by p53N236S mutation. This model provides direct evidence to connect mutant p53 DNA damage response with PKD development. The fact that the incidences of cystic kidneys increased along with telomere shortening suggests that DNA damage triggered the development of PKD.

To dissect the common genetic causes of PKD and tumorigenesis, we identified the upregulated pathways in tumors and cystic kidneys. Among the common pathways in cystic kidneys and tumors, the pathways of activation of complement, inflammatory response, and mitochondrial function were most significantly upregulated (**[Figure 3B](#Figure3){ref-type="fig"}** and **[3E](#Figure3){ref-type="fig"}**, **[Supplementary Figure S1](#FigureS1){ref-type="fig"}**). It has been documented that activation of the alternative complement pathway and the consequent inflammatory response plays an essential role in the progress of kidney diseases, such as atypical hemolytic uremic syndrome, C3 glomerulopathies, and atypical post infectious GN, as well as ADPKD^[@b28],[@b29]^. These data suggest the importance of complement cascade in the regulation of inflammatory response of both cystic kidney disease and tumors.

Mitochondrial function is essential in energy metabolism, oxygen consumption, ROS regulation, and ATP synthesis. Aside from kidney disease, mitochondrial dysfunction is also related to the processes of aging and tumor development ^[@b30],[@b31]^. By ssGSEA analysis, we found that the pathways involved in mitochondrial function and related fatty acid metabolisms are highly activated in tumors and cystic kidneys from G3TM mice; however, they are not significantly up-regulated in PKD1- or PKD2-deficient PKD^[@b22]^(**[Supplementary Table S1](#TableS1){ref-type="table"}**, **[S2](#TableS2){ref-type="table"}**).

It is very promising that we found that PKD1, PKD2, Pkhd1, and Hnf1b were all downregulated by the introduction of p53S (**[Figure 3D](#Figure3){ref-type="fig"}**). It has been documented that Hnf1b is the transcription factor for both Pkhd1 and PKD2. Mutation of Hnf1b results in kidney phenotypes that include renal agenesis, dysplasia, and cysts^[@b32]^. These phenotypes are consistent with our pathological analysis (**[Figure 2](#Figure2){ref-type="fig"}**).

Putting these data together, we report a novel PKD and tumor combined mouse model, and reveal the gene signatures involved in the development of PKD. The G3TM PKD model shared common pathways with classical PKD. These common pathways might be essential in PKD progress, and thus could be common targets for PKD prevention, drug screening, and patient care strategies. In depth analyses of these pathways could provide new biomarkers for the clinical diagnosis and prognosis of PKD (**[Figure 4](#Figure4){ref-type="fig"}**).

![A schematic of the establishment of G3TM PKD model, and the gene signatures shared between development of PKD and tumorigenesis, and with PKD1/2 PKD model.](cbm-16-1-79-4){#Figure4}
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